Search results
AstraZeneca's rare disease arm in $1 billion deal for Pfizer gene therapies
Reuters via Yahoo Finance· 10 months ago(Reuters) -AstraZeneca said on Friday its Alexion unit had agreed to buy U.S. drugmaker Pfizer's...
AstraZeneca gets FDA OK for rare disease drug acquired in Alexion buyout
BioPharma Dive via Yahoo Finance· 2 months agoThe approval of Voydeya as an add-on therapy for an uncommon blood disease validates a bet Alexion...
Why Are LogicBio Therapeutics Shares Skyrocketing Today?
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc's (NASDAQ: AZN) subsidiary, Alexion, has agreed to acquire LogicBio Therapeutics Inc...
AstraZeneca Q2 Highlights: Profits Fall, COVID-19 Vaccine Sales Dip, Lifts Annual Sales Guidance
Benzinga via Yahoo Finance· 2 years agoAstraZeneca Plc (NASDAQ: AZN) Q2 profits fell sharply on ballooning costs linked to its Alexion...
AstraZeneca to buy Amolyt Pharma for $1.05 billion to boost rare-disease portfolio
Reuters via Yahoo News· 3 months agoFrance's Amolyt, backed by investors including Danish drugmaker Novo Nordisk's parent firm Novo...
Is This Monster Stock on the Verge of a Home Run?
Motley Fool· 2 years agoLate last month, AstraZeneca's (NASDAQ: AZN) rare disease drug called Ultomiris received the green light from the European Commission to treat adult...
Two Dutchess County men accused of insider trading
Poughkeepsie Journal via Yahoo News· 11 months agoTwo Dutchess County men were among four defendants arrested in connection with a federal insider trading case announced this week. Damian Williams, the...
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake
Investor's Business Daily· 7 months agoActivist investor Elliott Investment Management has reportedly built a $1 billion stake in BioMarin...
Worried About a Recession? Park Your Money In These 2 High-Yielding Dividend Stocks
Motley Fool· 2 years agoTwo stocks that risk-averse investors should consider today are AstraZeneca (NASDAQ: AZN) and...
Amgen bets on ChemoCentryx's rare disease drug in $3.7 billion deal
Reuters via Yahoo News· 2 years ago(Reuters) -Amgen Inc on Thursday agreed to buy ChemoCentryx Inc for $3.7 billion to gain access to a...